FDA inspection

Carter BloodCare - Arlington: FDA inspection ending Oct 17, 2019

FDA inspection 1108391 · No Action Indicated (NAI) · Arlington, TX

Key facts

Inspection ID 1108391
Firm Carter BloodCare - Arlington
FEI number 1677509
Address 4780 Little Rd
City Arlington
State TX
ZIP 76017
Country United States
Fiscal year 2020
Inspection end date Oct 17, 2019
Classification No Action Indicated (NAI)
Project area Blood and Blood Products
Product type Biologics

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections